You are here

Advertising: Stakeholder engagement and reforms

31 July 2019

The TGA engages with stakeholders in a number of ways, including through the Therapeutic Goods Advertising Consultative Committee, other consultations, face to face education sessions, and webinars. Proposed changes to the advertising framework, including engagement strategies, will also be made available here.

Therapeutic Goods Advertising Consultative Committee (TGACC)

The TGACC provides a forum for the TGA to consult with consumer, industry, media, publishing, broadcasting and other non-industry bodies involved in the advertising of therapeutic goods to the public.

Advertising consultations

Using 'natural' claims when advertising to the public
The TGA has used several consultations to develop and refine guidance for advertisers that use 'natural' claims when advertising to the public. This sets out the reasons for releasing this guidance and how it was developed.

Advertising therapeutic goods (closed consultations & reviews)
Consultations and reviews that have occurred since 2017

Advertising reforms

Therapeutic goods advertising: update 31 July 2019
Advice on minor corrections and amendments made to the Therapeutic Goods Advertising Code (No.2) 2018. Important information about applications for pre-approval of medicines advertising.

The first six months: embedding the TGA advertising reforms
A recap of the important developments in therapeutic goods advertising regulation over the last six months and what we will focus on next.

Therapeutic goods advertising: Update 31 October 2018
The revised 2018 Code, the Therapeutic Goods Advertising Code (No.2) 2018, has been made. Guidance and a changes summary are also available.

Therapeutic goods advertising: Update 29 October 2018
Stakeholders have asked us about the compliance actions the TGA may take in relation to advertising that complies with the 2015 Code but not the 2018 Code.

Therapeutic goods advertising changes: Update 5 October 2018
An important update on a number of changes to the regulatory framework for advertising of therapeutic goods occurring in 2018 and early 2019.

Reforms to the therapeutic goods advertising framework
A number of changes to the regulatory framework for advertising of therapeutic goods will be made between 2018 and 2020.

Simplified and improved arrangements for handling therapeutic goods advertising complaints
From 1 July 2018, the Therapeutic Goods Administration (TGA) assumed responsibility for receiving and considering all complaints about therapeutic goods advertisements directed to the public under a simplified complaints system.

Advertising reforms questions & answers
Answers to commonly asked questions about the advertising reforms.

Advertising therapeutic goods (closed consultations & reviews)
Consultations and reviews that have occurred since 2017.